CHARGED ALPHA
Stock Detail
UNH Healthcare Latest YouTube: Q1 2026

UnitedHealth Group

Live stock metrics, chart context, a quarter-by-quarter YouTube archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Library coverage

Quarters tracked
1
YouTube quarters live
1
Latest video
Q1 2026
YouTube available
Yes
Current price
$324.63
+7.74 (+2.44%)
Trailing / Forward P/E
24.52x
Forward: 16.13x
Market cap / Volume
Volume:
Revenue / Earnings Growth
12.3%
Earnings: -99.9%
Margins
0.3% op
Gross: 18.5% · Net: 2.7%
Balance sheet
0.79x current
Debt / Equity: 81.6
52-week range / Beta
$234.60 - $453.50
Beta: 0.41
Analyst target
$360.46
Upside: 11.0%
Cash / shareholder return
4.70% FCF yield
Dividend yield: 2.76%

Company context

Industry: Healthcare Plans
Country: United States
Employees:
Price to book: 3.13x
Return on equity: 12.5%
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Price chart

Market context for UNH

Competitive view

UNH vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

UnitedHealth Group
UNH
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Merck & Co.
MRK
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Johnson & Johnson
JNJ
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
UNH
$294.66B
UnitedHealth Group
MRK
$294.39B
Merck & Co.
JNJ
$564.35B
Johnson & Johnson
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
UNH
24.5x
UnitedHealth Group
MRK
16.4x
Merck & Co.
JNJ
21.2x
Johnson & Johnson
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
UNH
16.1x
UnitedHealth Group
MRK
12.2x
Merck & Co.
JNJ
18.4x
Johnson & Johnson
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
UNH
12.3%
UnitedHealth Group
MRK
5.0%
Merck & Co.
JNJ
9.9%
Johnson & Johnson
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
UNH
-99.9%
UnitedHealth Group
MRK
-19.3%
Merck & Co.
JNJ
-52.9%
Johnson & Johnson
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
UNH
0.3%
UnitedHealth Group
MRK
32.8%
Merck & Co.
JNJ
26.7%
Johnson & Johnson
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
UNH
18.5%
UnitedHealth Group
MRK
77.2%
Merck & Co.
JNJ
68.0%
Johnson & Johnson
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
UNH
2.7%
UnitedHealth Group
MRK
28.1%
Merck & Co.
JNJ
21.8%
Johnson & Johnson
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
UNH
12.5%
UnitedHealth Group
MRK
36.9%
Merck & Co.
JNJ
Johnson & Johnson
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
UNH
4.7%
UnitedHealth Group
MRK
4.0%
Merck & Co.
JNJ
3.4%
Johnson & Johnson
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
UNH
81.62x
UnitedHealth Group
MRK
95.96x
Merck & Co.
JNJ
60.50x
Johnson & Johnson
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
UNH
0.79x
UnitedHealth Group
MRK
1.54x
Merck & Co.
JNJ
1.03x
Johnson & Johnson
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
UNH
0.41
UnitedHealth Group
MRK
0.28
Merck & Co.
JNJ
0.33
Johnson & Johnson
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
UNH
2.8%
UnitedHealth Group
MRK
2.8%
Merck & Co.
JNJ
2.2%
Johnson & Johnson
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
UNH
11.0%
UnitedHealth Group
MRK
9.0%
Merck & Co.
JNJ
7.2%
Johnson & Johnson

YouTube timeline

Quarterly archive for UNH

Each row is one quarter. Only the YouTube link is shown here for now.

Q1 2026
Video live
Published youtube complete
Quarterly earnings-analysis entry for UnitedHealth Group. Use the YouTube link on the right to jump straight into that quarter's video when it is live.